@article{7e97815f2a854604b093847d3b8952e5,
title = "African-specific alleles modify risk for asthma at the 17q12-q21 locus in African Americans",
abstract = "Background: Asthma is the most common chronic disease in children, occurring at higher frequencies and with more severe disease in children with African ancestry. Methods: We tested for association with haplotypes at the most replicated and significant childhood-onset asthma locus at 17q12-q21 and asthma in European American and African American children. Following this, we used whole-genome sequencing data from 1060 African American and 100 European American individuals to identify novel variants on a high-risk African American–specific haplotype. We characterized these variants in silico using gene expression and ATAC-seq data from airway epithelial cells, functional annotations from ENCODE, and promoter capture (pc)Hi-C maps in airway epithelial cells. Candidate causal variants were then assessed for correlation with asthma-associated phenotypes in African American children and adults. Results: Our studies revealed nine novel African-specific common variants, enriched on a high-risk asthma haplotype, which regulated the expression of GSDMA in airway epithelial cells and were associated with features of severe asthma. Using ENCODE annotations, ATAC-seq, and pcHi-C, we narrowed the associations to two candidate causal variants that are associated with features of T2 low severe asthma. Conclusions: Previously unknown genetic variation at the 17q12-21 childhood-onset asthma locus contributes to asthma severity in individuals with African ancestries. We suggest that many other population-specific variants that have not been discovered in GWAS contribute to the genetic risk for asthma and other common diseases.",
keywords = "Asthma, Fine mapping, Health disparities, Integrated omics, Whole-genome sequencing",
author = "CAAPA and Charles Washington and Matthew Dapas and Arjun Biddanda and Magnaye, {Kevin M.} and Ivy Aneas and Helling, {Britney A.} and Brooke Szczesny and Boorgula, {Meher Preethi} and Taub, {Margaret A.} and Eimear Kenny and Mathias, {Rasika A.} and Barnes, {Kathleen C.} and Monica Campbell and Camila Figueiredo and Hansel, {Nadia N.} and Carole Ober and Olopade, {Christopher O.} and Rotimi, {Charles N.} and Harold Watson and {Khurana Hershey}, {Gurjit K.} and Kercsmar, {Carolyn M.} and Gereige, {Jessica D.} and Melanie Makhija and Gruchalla, {Rebecca S.} and Gill, {Michelle A.} and Liu, {Andrew H.} and Deepa Rastogi and William Busse and Gergen, {Peter J.} and Visness, {Cynthia M.} and Gold, {Diane R.} and Tina Hartert and Johnson, {Christine C.} and Lemanske, {Robert F.} and Martinez, {Fernando D.} and Miller, {Rachel L.} and Dennis Ownby and Seroogy, {Christine M.} and Wright, {Anne L.} and Zoratti, {Edward M.} and Bacharier, {Leonard B.} and Meyer Kattan and O{\textquoteright}Connor, {George T.} and Wood, {Robert A.} and Nobrega, {Marcelo A.} and Altman, {Matthew C.} and Jackson, {Daniel J.} and Gern, {James E.} and McKennan, {Christopher G.} and Carole Ober",
note = "Funding Information: This work was supported by U19 AI62310, UG3 OD023282, R01 HL104608, UM1 AI114271, UM1 AI160040, UM2 AI117870, U19 AI095230, UL1 TR001430, UL1 TR001079, UL1 TR000150, UL1 RR025780, UL1 TR000451, UL1 TR001105, UL1 TR000040, UL1 TR000075, UL1 TR000077, HHSN272200900052C, and HHSN272201000052I. CCTSI is supported in part by Colorado CTSA Grant UL1 TR000154 from NCATS/NIH UL1 TR001082. GlaxoSmithKline (GSK) provided Ventolin HFA, Flonase, Flovent 50 mcg, Flovent 100 mcg, Flovent 250 mcg, Advair 250/50 mcg, and Advair 500/50 mcg under a clinical trial agreement with NIH NIAID in the APIC cohort. C.W. was supported by an HHMI Gilliam Fellowship GT10892, M.D. was supported by TL1 TR002388 and T32 HL007605, and K.M.M was supported by F31 HL143891. P.J.G.{\textquoteright}s co-authorship of this publication does not necessarily constitute endorsement by the National Institute of Allergy and Infectious Diseases, the National Institutes of Health or any other agency of the United States government. The Consortium on Asthma among African-Ancestry Populations in the Americas (CAAPA) was supported by the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) grant R01 HL104608 and the Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico (CNPq) grant 471057/2014-2, for submitting CAAPA whole-genome sequence data to dbGaP. In addition, sections of research reported in this article were supported by the following: EDCTP:CT,2011,40200,025, EU-IDEA HEALTH-F3-2009-241642, TheSchistoVac,G12RR003048, HEALTH-Fe-2009-242107, EU- HL087699, HL081332, HL112656, HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C, HHSN268201300046C, HHSN268201300047C, HHSN268201300048C, HHSN268201300049C, HHSN268201300050C,K01HL092601, K08AI01582, K24 AI 77930, NSFGRF #1144247, P20MD006688,P50CA125183, P60MD006902, R01HG007644, R01HL087699, R01HL118267, R01HL117004, R01HL088133, R01HL004464, R01HL69167, R01HL072414, R01HL089897, R01HL089856, R01HL51492, R01HL/AI67905, R01AI079139, R01ES015794, R01HL104608, R01ES018845, R01HL104608, R01HL129239, R21CA178706, R21HG007233,R21HG004751, RC2HL101651, RC2HL101543, RR24975, S06GM008016-320107, S06GM008016-380111, S06GM08016, T32HG000044, T32GM07175, U01CA161032, 1U01HG007416-01; 1U01HG007376-01; 1U01HG007397-01; 1U01HG007417-01, U01HL109164, U01HL49596, UL1 TR00445, U19AI095230, U19 AI95227, 2M01RR010284, 331-2004, 680-2009,072405/Z/03/Z, and 088862/Z/09/Z 8U54MD007588. Authorized access to genotype data may be obtained through accession number phs001123. For the full list of investigators and institutions and for the specific cohort descriptions and descriptions regarding the collection of phenotype data that contributed to CAAPA can be found at: https://www.caapa-project.org/ . The authors wish to give special recognition to the individual CAAPA study participants who provided biological samples and or data, without their support in research none of this would be possible. Funding Information: The authors thank the study personnel from the CREW, URECA, APIC, CAAPA2, and CAG cohorts, Chris Reyes for editorial assistance and help in preparing the manuscript, and Noboru Sakabe for assistance in making figures. CAAPA Site Principal Investigators : Monica Campbell (University of Colorado, Aurora, CO), Camila Figueiredo (University of Bahia, Salvador, Brazil), Nadia N. Hansel (Johns Hopkins University, Baltimore), Carole Ober (University of Chicago, Chicago), Christopher O. Olopade (University of Chicago, Chicago), Charles N. Rotimi (National Human Genome Center, Bethesda and Howard University College of Medicine, Washington, D.C.), Harold Watson (University of West Indies, Barbados), Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2022",
month = dec,
doi = "10.1186/s13073-022-01114-x",
language = "English",
volume = "14",
journal = "Genome medicine",
issn = "1756-994X",
number = "1",
}